Ceriello, Antonio http://orcid.org/0000-0001-8122-3203
De Nigris, Valeria http://orcid.org/0000-0002-7556-4906
Iijima, Hiroaki http://orcid.org/0000-0003-4621-2394
Matsui, Takahiro
Gouda, Maki http://orcid.org/0000-0003-2722-5202
Article History
First Online: 13 April 2019
Compliance with Ethical Standards
:
: Antonio Ceriello has received research grants from Mitsubishi Tanabe Pharma Co., Astra Zeneca, Eli Lilly, and Novartis; consulting fees or honorarium from Astra Zeneca, Boehringer Ingelheim, DOC Generici, Eli Lilly, Janssen, Novo Nordisk, and OM Pharma; and payment for lectures, including service on speakers bureaus, from Astra Zeneca, Boehringer Ingelheim, Eli Lilly, Novartis, Novo Nordisk, Sanofi, and Takeda. Valeria De Nigris has no conflicts of interest to declare. Hiroaki Iijima, Takahiro Matsui, and Maki Gouda are employees of Mitsubishi Tanabe Pharma Corporation.
: For this review, consent was not required.